Literature DB >> 8794318

The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.

G R Kovacs1, B Moss.   

Abstract

The vaccinia virus late stage-specific transcription factor P3 was purified to homogeneity from HeLa cells that were infected in the presence of an inhibitor of viral DNA replication. The purified 36-kDa protein was digested with trypsin, and the peptides were analyzed by mass spectroscopy and amino-terminal sequencing. The purified factor was identified as the product of the vaccinia virus H5R open reading frame by both methods. A recombinant baculovirus was engineered to express the H5R open reading frame. The partially purified recombinant protein could replace the vaccinia virus P3 factor in transcription assays. On the basis of these findings, we assigned the H5R gene product the name viral late gene transcription factor 4 (VLTF-4). Unlike VLTF-1, -2, and -3, which are synthesized exclusively after viral DNA replication, VLTF-4 is synthesized before and after viral DNA synthesis. Indirect immunofluorescence of infected cells with anti-H5R protein antiserum demonstrated that VLTF-4 is diffusely distributed in the cytoplasm when DNA replication is blocked but is localized to discrete viral DNA-containing factories during a productive infection. Its expression pattern and subcellular distribution suggest that the H5R gene product may have multiple roles in the viral life cycle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794318      PMCID: PMC190724     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Early transcription factor subunits are encoded by vaccinia virus late genes.

Authors:  P D Gershon; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Transcription of a vaccinia virus late promoter template: requirement for the product of the A2L intermediate-stage gene.

Authors:  A L Passarelli; G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  Identification of factors specific for transcription of the late class of vaccinia virus genes.

Authors:  C F Wright; B Moss
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  Polyadenylate polymerase from vaccinia virions.

Authors:  B Moss; E N Rosenblum; E Paoletti
Journal:  Nat New Biol       Date:  1973-09-12

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  A soluble transcription system derived from purified vaccinia virions.

Authors:  F Golini; J R Kates
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

7.  mRNA guanylyltransferase and mRNA (guanine-7-)-methyltransferase from vaccinia virions. Donor and acceptor substrate specificites.

Authors:  S A Martin; B Moss
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

8.  Identification of the gene encoding vaccinia virus immunodominant protein p35.

Authors:  V V Zinoviev; N A Tchikaev; E G Malygin
Journal:  Gene       Date:  1994-09-30       Impact factor: 3.688

9.  Cap-specific mRNA (nucleoside-O2'-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein.

Authors:  B S Schnierle; P D Gershon; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

10.  Vaccinia virus capping enzyme is a transcription initiation factor.

Authors:  J C Vos; M Sasker; H G Stunnenberg
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

View more
  36 in total

1.  Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase.

Authors:  G R Kovacs; N Vasilakis; B Moss
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Genome-wide analysis of vaccinia virus protein-protein interactions.

Authors:  S McCraith; T Holtzman; B Moss; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis.

Authors:  J DeMasi; P Traktman
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Clustered charge-to-alanine mutagenesis of the vaccinia virus A20 gene: temperature-sensitive mutants have a DNA-minus phenotype and are defective in the production of processive DNA polymerase activity.

Authors:  A Punjabi; K Boyle; J DeMasi; O Grubisha; B Unger; M Khanna; P Traktman
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants.

Authors:  K Ishii; B Moss
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Relationship between vaccinia virus intracellular cores, early mRNAs, and DNA replication sites.

Authors:  Massimo Mallardo; Edward Leithe; Sibylle Schleich; Norbert Roos; Laura Doglio; Jacomine Krijnse Locker
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling.

Authors:  Zhilong Yang; Shuai Cao; Craig A Martens; Stephen F Porcella; Zhi Xie; Ming Ma; Ben Shen; Bernard Moss
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

8.  Vaccinia virus H7 protein contributes to the formation of crescent membrane precursors of immature virions.

Authors:  P S Satheshkumar; Andrea Weisberg; Bernard Moss
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

9.  The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.

Authors:  Y Xiang; D A Simpson; J Spiegel; A Zhou; R H Silverman; R C Condit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters.

Authors:  Zhilong Yang; Liliana Maruri-Avidal; Jerry Sisler; Carey A Stuart; Bernard Moss
Journal:  Virology       Date:  2013-10-03       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.